Doximity (DOCS) Stock Price, News & Analysis

Company Overview

Doximity, Inc., headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities. Through the Doximity Dialer product, users can make voice and video calls without revealing personal phone numbers, facilitating virtual patient consultations and inter-professional collaboration. The platform also aggregates tailored medical news and research updates, helping clinicians keep pace with developments in their fields.

In addition to its communication tools, Doximity provides solutions for medical education and career advancement. The platform hosts continuing medical education (CME) courses and offers a job board that connects healthcare organizations with qualified candidates. Pharmaceutical and medical device companies leverage Doximity’s targeted marketing products to reach relevant clinician audiences while adhering to privacy regulations.

Under the leadership of co-founder and CEO Jeff Tangney, Doximity has grown to include over 1.8 million verified healthcare professionals—representing a substantial majority of U.S. physicians. While its primary focus remains on the domestic market, the company continues to explore adjacent services and partnerships aimed at improving clinical workflows and patient access through digital innovation.

Key Stats

• Today's Range: $70.50 to $71.98
• 50-Day Range: $57.30 to $71.05
• 52-Week Range: $38.30 to $85.21
• Volume: 1.37 million shs
• Average Volume: 2.22 million shs
• Market Capitalization: $13.31 billion
• P/E Ratio: 71.05
• Dividend Yield: N/A
• Price Target: $67.00
• Consensus Rating: Moderate Buy

Doximity Stock Analysis - MarketRank™

Doximity scored higher than 65% of companies evaluated by MarketBeat, and ranked 380th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Doximity has received a consensus rating of Moderate Buy. The company's average rating score is 2.61, and is based on 10 buy ratings, 11 hold ratings, and no sell ratings.

Downside Risk

Doximity has a consensus price target of $67.00, representing about 5.7% downside from its current price of $71.05.

Amount of Analyst Coverage

Doximity has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.08%

Earnings Growth

Earnings for Doximity are expected to grow by 8.08% in the coming year, from $0.99 to $1.07 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Doximity is 71.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of Doximity is 71.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.20.

Price to Earnings Growth Ratio

Doximity has a PEG Ratio of 4.10. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Doximity has a P/B Ratio of 12.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DOCS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Doximity does not currently pay a dividend.

Dividend Growth

Doximity does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for DOCS.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.18

News Sentiment

Doximity has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for Doximity this week, compared to 14 articles on an average week.

Search Interest

Only 9 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -31% compared to the previous 30 days.

MarketBeat Follows

8 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,929,380.00 in company stock.

Percentage Held by Insiders

31.30% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DOCS Stock Analysis - Frequently Asked Questions

How have DOCS shares performed this year?

Doximity's stock was trading at $53.39 at the beginning of 2025. Since then, DOCS stock has increased by 33.1% and is now trading at $71.0530.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) announced its quarterly earnings results on Thursday, August, 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. The company's quarterly revenue was up 15.2% compared to the same quarter last year.

When did Doximity IPO?

Doximity (DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Who are Doximity's major shareholders?

Doximity's top institutional investors include William Blair Investment Management LLC (2.78%), State Street Corp (2.15%), Geode Capital Management LLC (1.94%) and Franklin Resources Inc. (1.68%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Regina M Benjamin, Kira Scherer Wampler, Watkin Phoebe L Yang and Timothy S Cabral.
View institutional ownership trends.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Doximity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/13/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Custom computer programming services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:DOCS
• CIK: 1516513
• Web: www.doximity.com
• Phone: 650-549-4330
• Fax: N/A
• Employees: 890
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Doximity: $67.00
• High Price Target: $90.00
• Low Price Target: $50.00
• Potential Upside/Downside: -5.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.61
• Research Coverage: 23 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.17
• Trailing P/E Ratio: 71.05
• Forward P/E Ratio: 71.77
• P/E Growth: 4.1
• Net Income: $147.58 million
• Net Margins: 36.60%
• Pretax Margin: 46.01%
• Return on Equity: 21.75%
• Return on Assets: 18.64%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.74
• Quick Ratio: 8.74

Sales & Book Value

• Annual Sales: $589.64 million
• Price / Sales: 22.57
• Cash Flow: $0.87 per share
• Price / Cash Flow: 81.32
• Book Value: $5.52 per share
• Price / Book: 12.87

Miscellaneous

• Outstanding Shares: 187,299,000
• Free Float: 116,869,000
• Market Cap: $13.31 billion
• Optionable: Not Optionable
• Beta: 1.37